1. Home
  2. GRDN vs SABR Comparison

GRDN vs SABR Comparison

Compare GRDN & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • SABR
  • Stock Information
  • Founded
  • GRDN 2004
  • SABR 2006
  • Country
  • GRDN United States
  • SABR United States
  • Employees
  • GRDN N/A
  • SABR N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • SABR Computer Software: Programming Data Processing
  • Sector
  • GRDN Consumer Staples
  • SABR Technology
  • Exchange
  • GRDN Nasdaq
  • SABR Nasdaq
  • Market Cap
  • GRDN 1.4B
  • SABR 1.3B
  • IPO Year
  • GRDN 2024
  • SABR 2014
  • Fundamental
  • Price
  • GRDN $20.67
  • SABR $3.34
  • Analyst Decision
  • GRDN Strong Buy
  • SABR Hold
  • Analyst Count
  • GRDN 2
  • SABR 4
  • Target Price
  • GRDN $22.50
  • SABR $3.50
  • AVG Volume (30 Days)
  • GRDN 229.7K
  • SABR 3.7M
  • Earning Date
  • GRDN 02-15-2025
  • SABR 02-13-2025
  • Dividend Yield
  • GRDN N/A
  • SABR N/A
  • EPS Growth
  • GRDN N/A
  • SABR N/A
  • EPS
  • GRDN N/A
  • SABR N/A
  • Revenue
  • GRDN $1,170,907,000.00
  • SABR $3,001,894,000.00
  • Revenue This Year
  • GRDN $18.05
  • SABR $6.30
  • Revenue Next Year
  • GRDN $9.55
  • SABR $5.01
  • P/E Ratio
  • GRDN N/A
  • SABR N/A
  • Revenue Growth
  • GRDN 16.86
  • SABR 5.26
  • 52 Week Low
  • GRDN $14.16
  • SABR $1.81
  • 52 Week High
  • GRDN $25.74
  • SABR $4.60
  • Technical
  • Relative Strength Index (RSI)
  • GRDN N/A
  • SABR 40.04
  • Support Level
  • GRDN N/A
  • SABR $3.19
  • Resistance Level
  • GRDN N/A
  • SABR $3.42
  • Average True Range (ATR)
  • GRDN 0.00
  • SABR 0.11
  • MACD
  • GRDN 0.00
  • SABR -0.03
  • Stochastic Oscillator
  • GRDN 0.00
  • SABR 27.27

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.

About SABR Sabre Corporation

Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2023 revenue, split between distribution (78% of segment sales) and airline IT solutions (22%) revenue. The company also has a growing hotel IT solutions division (9% of revenue). Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.

Share on Social Networks: